Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study

Hanon, Olivier; Vidal, Jean‐Sébastien; Lehmann, Sylvain; Bombois, Stéphanie; Allinquant, Bernadette; Baret‐Rose, Christiane; Tréluyer, Jean‐Marc; Abdoul, Hendy; Gelé, Patrick; Delmaire, Christine; Blanc, Fredéric; Mangin, Jean‐François; Buée, Luc; Touchon, Jacques; Hugon, Jacques; Vellas, Bruno; Galbrun, Evelyne; Benetos, Athanase; Berrut, Gilles; Paillaud, Elena; Wallon, David; Castelnovo, Giovanni; Volpe‐Gillot, Lisette; Paccalin, Marc; Robert, Philippe; Godefroy, Olivier; Camus, Vincent; Belmin, Joël; Vandel, Pierre; Novella, Jean‐Luc; Duron, Emmanuelle; Rigaud, Anne‐Sophie; Schraen‐Maschke, Susanna; Gabelle, Audrey; BALTAZAR study group, the

doi:10.1002/alz.12613

Public

Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study

Shared by NobleBlocks on Feb 20, 2022 • 12:00 AM UTC

Authors:

Olivier Hanon

Jean‐Sébastien Vidal

Sylvain Lehmann

Abstract

Abstract Introduction Blood‐based biomarkers are the next challenge for Alzheimer's disease (AD) diagnosis and prognosis. Methods Mild cognitive impairment (MCI) participants (N = 485) of the BALTAZAR study, a large‐scale longitudinal multicenter cohort, were followed‐up for 3 years. A total of 165 ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!